Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Cruz, E
I started my journey with the clinic in February this year
Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial
Sampedro F, Martnez-Horta S, Horta-Barba A, Grothe MJ, Labrador-Espinosa MA, Jess S, Adarmes-Gmez A, Carrillo F, Puig-Davi A, Lora FR, Barber MA (2022) Increased homocysteine levels correlate with cortical structural damage in Parkinsons disease
US$ 20.45
US$ 22.72
US$ 24.87
US$ 22.58
US$ 20.84
